GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed under U.S. President Donald Trump.
GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed under U.S. President Donald Trump.
GE (GE) HealthCare Technologies’ stock rose early Wednesday after the company reported better-than-expected quarterly results and offered a solid outlook for the new year.
GE Healthcare Technologies Inc. is considering selling a stake in its China operations, according to a report from Bloomberg News, citing people familiar with the matter.
GE HealthCare GEHC+4.96% Technologies reported better-than-expected first-quarter earnings. That’s the good news. The bad news is guidance was cut due to the impact of tariffs.
GE HealthCare Technologies reported better-than-expected third-quarter earnings and raised its full-year guidance. Shares rose in early trading
Shares of GE HealthCare Technologies dropped Tuesday after the company reported first-quarter results that missed Wall Street projections.
GE HealthCare Technologies Inc.’s stock slid 3.3% early Monday, after UBS downgraded the stock to sell from neutral and cut its price target to $66 from $86, warning of margin disappointments ahead.
GE Healthcare Technologies 0.11% reported better-than-expected third-quarter earnings and profit margins. Shares were stable in early trading.
General Electric Co (GE.N) is offering 25 million of common stock, or an over $2 billion stake, in GE HealthCare Technologies Inc (GEHC.O), according to a regulatory filing on Monday.